RE: Interferon10 May 2020 09:52
It is really interesting to see the success some trials have already had around the world and not in such a controlled environment. I think this week will be positive, news on hospital trial completion and home trial outline and start date. I think they have held off to announce the two together, I suspect the hospital trial has recruited as Soton and Leicester are no longer taking patients that suggests to me they have reached the 100 especially given Soton is the prime site. TR1 on Lansdowne selling and I expect this weeks trading and SP performance to indicate their position. If we have another week in the 50’s early 60’s then I expect them to sell out, if we see the SP rerate without news I expect them to hold at 10%. Another week close to June and none of us know when results will come, start mid end of June the company has indicated end of June but might come sooner, will they announce results together or separately? This can only get better as we approach June people will want in and I can see 80p to £1 range end of this month, regardless of any seller. Oil COPD data will come this summer IMO they won’t put all their eggs in the Covid basket and it wouldn’t be the most effective bargaining position to just have Covid data on the table when they come to discuss partnering or takeover. They will complete the COPD data as well and bring this to the table, that’s why they raised and allocated 3 million in the placing. It’s only 11 patients to produce data for they will do it now, yes they paused initially when the Covid trial started but the Chairman’s letter clearly states Summer 2020 results.